NCT02716701

Brief Summary

Exercise therapy in MS patients has proven benefits on mobility, mood, motor function and quality of life. While the beneficial effects of exercise on cardiovascular and musculoskeletal function are well known, there has recently been increased focus on the positive effects of exercise on brain structure and function. The goal of this study is to determine whether exercise can promote beneficial changes in brain function in MS patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 23, 2016

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 13, 2020

Completed
Last Updated

August 25, 2020

Status Verified

August 1, 2020

Enrollment Period

4.6 years

First QC Date

March 10, 2016

Last Update Submit

August 20, 2020

Conditions

Keywords

Exercise

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in brain structure as measured by magnetic resonance imaging scans at 7 months

    Magnetic resonance imaging (MRI) scans will be done at 1 month (baseline) and 7 months after subjects begin wearing a wristband activity tracker.

    7 months

  • Change from baseline in brain structure as measured by magnetoencephalography (MEG) scans at 7 months

    MEG scans will be done at 1 month (baseline) and 7 months after subjects begin wearing a wristband activity tracker

    7 months

Study Arms (2)

Exercise Group

EXPERIMENTAL

Subjects will wear a wristband activity tracker to monitor their physical activity and will be asked to increase their activity level, with a goal of at least doubling their average daily activity (steps)

Behavioral: Exercise GroupOther: wristband activity tracker

Control Group

ACTIVE COMPARATOR

Subjects will wear a wristband activity tracker to monitor their physical activity and will not be encouraged to increase their activity level

Other: Control GroupOther: wristband activity tracker

Interventions

Exercise GroupBEHAVIORAL
Exercise Group
Control Group
Control GroupExercise Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients with a confirmed diagnosis of MS by revised McDonald criteria
  • Age ≥ 18 years
  • Expanded Disability Status Scale (EDSS) 0-6.0, inclusive.
  • Able to understand the consent process, and the use of the wristband activity tracker.
  • Sedentary by self-report (answers no to the question: "Do you exercise regularly?"
  • Willing to make sincere effort to comply with the study objective of increasing their physical activity as much as possible (with goal of at least 100% increase) and to maintain that increased activity level for six months (if randomized to the exercise group).

You may not qualify if:

  • Current serious medical condition which would likely limit subject's ability to achieve sustained increase in physical activity, or put them at risk for doing so in the investigators' opinion (e.g. significant cardiovascular or respiratory disease, cancer, cancer, orthopedic disease, etc)
  • Subjects that have a central nervous system disorder (in addition to MS) that is not considered secondary to MS
  • Subjects that have implanted metal, pacemaker, etc. that may interfere with the MEG/MRI scan or who are otherwise unable to complete the MEG/MRI scan procedure without sedation (e.g. due to claustrophobia, obesity)
  • weight \> 300 pounds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Medical Center

Minneapolis, Minnesota, 55417, United States

Location

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Adam F Carpenter, MD

    Minneapolis Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2016

First Posted

March 23, 2016

Study Start

January 1, 2016

Primary Completion

August 12, 2020

Study Completion

August 13, 2020

Last Updated

August 25, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations